Pharmacokinetics and Safety of Fluconazole in Young Infants Supported with Extracorporeal Membrane Oxygenation

BACKGROUND: Candida infections are a leading cause of infectious disease-related death in infants supported with extracorporeal membrane oxygenation (ECMO). The ECMO circuit can alter drug pharmacokinetics (PK), thus standard fluconazole dosing in children on ECMO may result in suboptimal drug expos...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Watt, Kevin M., Benjamin, Daniel K., Cheifetz, Ira M., Moorthy, Ganesh, Wade, Kelly C., Smith, P. Brian, Brouwer, Kim L. R., Capparelli, Edmund V., Cohen-Wolkowiez, Michael
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3444624/
https://ncbi.nlm.nih.gov/pubmed/22627870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e31825d3091
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items